Log in to save to my catalogue

Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B

Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_223917247

Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B

About this item

Full title

Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B

Publisher

Waltham, MA: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2008-12, Vol.359 (23), p.2442-2455

Language

English

Formats

Publication information

Publisher

Waltham, MA: Massachusetts Medical Society

More information

Scope and Contents

Contents

In this randomized comparison of treatment with tenofovir disoproxil fumarate or adefovir dipivoxil for 48 weeks in patients with chronic hepatitis B, tenofovir was more likely to result in viral suppression. The follow-up period was not long enough to assess the resistance patterns, risks, and benefits of long-term treatment.
In this randomized...

Alternative Titles

Full title

Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_223917247

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_223917247

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa0802878

How to access this item